Leveraging Sensory Data in Estimating Transformer Lifetime

Transformer lifetime assessments plays a vital role in reliable operation of power systems. In this paper, leveraging sensory data, an approach in estimating transformer lifetime is presented. The winding hottest-spot temperature, which is the pivotal driver that impacts transformer aging, is measured hourly via a temperature sensor, then transformer loss of life is calculated based on the IEEE Std. C57.91-2011. A Cumulative Moving Average (CMA) model is subsequently applied to the data stream of the transformer loss of life to provide hourly estimates until convergence. Numerical examples demonstrate the effectiveness of the proposed approach for the transformer lifetime estimation, and explores its efficiency and practical merits.Comment: 2017 North American Power Symposium (NAPS), Morgantown, WV, 17-19 Sep. 201

Mechanistic model for hydrogen accelerated fatigue crack growth in a low carbon steel

Please click Additional Files below to see the full abstrac

Stochastic Security Constrained Unit Commitment with High Penetration of Wind Farms

Secure and reliable operation is one of the main challenges in restructured power systems. Wind energy has been gaining increasing global attention as a clean and economic energy source, despite the operational challenges its intermittency brings. In this study, we present a formulation for electricity and reserve market clearance in the presence of wind farms. Uncertainties associated with generation and line outages are modeled as different system scenarios. The formulation incorporates the cost of different scenarios in a two-stage short-term (24-hours) clearing process, also considering different types of reserve. The model is then linearized in order to be compatible with standard mixed-integer linear programming solvers, aiming at solving the security constrained unit-commitment problem using as few variables and optimization constraints as possible. As shown, this will expedite the solution of the optimization problem. The model is validated by testing it on a case study based on the IEEE RTS1, for which results are presented and discussed.© 2019 IEEE. Personal use of this material is permitted. Permission from IEEE must be obtained for all other uses, in any current or future media, including reprinting/republishing this material for advertising or promotional purposes, creating new collective works, for resale or redistribution to servers or lists, or reuse of any copyrighted component of this work in other works.fi=vertaisarvioitu|en=peerReviewed

Global, regional, and national burden of chronic kidney disease, 1990–2017 : a systematic analysis for the Global Burden of Disease Study 2017

Background Health system planning requires careful assessment of chronic kidney disease (CKD) epidemiology, but data for morbidity and mortality of this disease are scarce or non-existent in many countries. We estimated the global, regional, and national burden of CKD, as well as the burden of cardiovascular disease and gout attributable to impaired kidney function, for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017. We use the term CKD to refer to the morbidity and mortality that can be directly attributed to all stages of CKD, and we use the term impaired kidney function to refer to the additional risk of CKD from cardiovascular disease and gout. Methods The main data sources we used were published literature, vital registration systems, end-stage kidney disease registries, and household surveys. Estimates of CKD burden were produced using a Cause of Death Ensemble model and a Bayesian meta-regression analytical tool, and included incidence, prevalence, years lived with disability, mortality, years of life lost, and disability-adjusted life-years (DALYs). A comparative risk assessment approach was used to estimate the proportion of cardiovascular diseases and gout burden attributable to impaired kidney function. Findings Globally, in 2017, 1·2 million (95% uncertainty interval [UI] 1·2 to 1·3) people died from CKD. The global all-age mortality rate from CKD increased 41·5% (95% UI 35·2 to 46·5) between 1990 and 2017, although there was no significant change in the age-standardised mortality rate (2·8%, −1·5 to 6·3). In 2017, 697·5 million (95% UI 649·2 to 752·0) cases of all-stage CKD were recorded, for a global prevalence of 9·1% (8·5 to 9·8). The global all-age prevalence of CKD increased 29·3% (95% UI 26·4 to 32·6) since 1990, whereas the age-standardised prevalence remained stable (1·2%, −1·1 to 3·5). CKD resulted in 35·8 million (95% UI 33·7 to 38·0) DALYs in 2017, with diabetic nephropathy accounting for almost a third of DALYs. Most of the burden of CKD was concentrated in the three lowest quintiles of Socio-demographic Index (SDI). In several regions, particularly Oceania, sub-Saharan Africa, and Latin America, the burden of CKD was much higher than expected for the level of development, whereas the disease burden in western, eastern, and central sub-Saharan Africa, east Asia, south Asia, central and eastern Europe, Australasia, and western Europe was lower than expected. 1·4 million (95% UI 1·2 to 1·6) cardiovascular disease-related deaths and 25·3 million (22·2 to 28·9) cardiovascular disease DALYs were attributable to impaired kidney function. Interpretation Kidney disease has a major effect on global health, both as a direct cause of global morbidity and mortality and as an important risk factor for cardiovascular disease. CKD is largely preventable and treatable and deserves greater attention in global health policy decision making, particularly in locations with low and middle SDI